… Here we explore and discuss challenges in vaccine development against A. baumannii
and the promising approaches for improving the vaccine development process. …

… Although MDRAB has emerged as a global problem, its impact is particularly serious in low-
and middle-income regions such as Africa, straining already limited healthcare resources in …

… This problem is most apparent in healthcare facilities, with a comparatively small number …
globally. One of the key pathogens is the Gram-negative coccobacilli, Acinetobacter baumannii…

… The increase in the prevalence of multidrug-resistant Acinetobacter baumannii infections
in hospital settings has rapidly emerged worldwide as a serious health problem. …

… We have already entered the post-antibiotic era as the outbreaks of numerous multidrug-resistant …
Acinetobacter baumannii is one such pathogen that has been considered a worldwide …

… to eliminate infections with multidrug-resistant Gram-negative bacteria, is a major concern.
Carbapenems resistant A. baumannii (CR-Ab) is a worldwide problem. Because these strains …

… of healthcare-associated infections globally, particularly in … have been recognized as a
global challenge because of its … that multidrug-resistant Gram-negative bacteria, including A. …

… The objective of this works was to assess the global prevalence of multidrug-resistance
among A. baumannii causing hospital-acquired (HAP) and ventilator-associated pneumonia (…

… become the last resort of treatment for multidrug-resistant (MDR) A. baumannii; however,
colistin-resistant strains have been reported in different regions from around the world [17]. …

… Acinetobacter baumannii is a Gram-negative … growing problem in hospitals as a predominant
multidrug-resistant (MDR) bacterium in the intensive care and burn units [1,2]. A. baumannii …